Suggested as a cancer biomarker, a recent publication indicated that the concomitant expression of CDC42 and CACNA2D2 shows improved power as CDC42 alone, in the context of CRC diagnosis [174]. The gene discussed is CDC42; the disease is colorectal carcinoma.